| Thesaurus |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Stocks Mutual Funds > The Rules of a Professsional Stock Market Trader |
|
Thesaurus - The Rules of a Professsional Stock Market Trader
In today’s market the large institutions are buying shares by the millions. This is a huge demand on the stock and when demand is high the share price rises. So I make sure that the stock is being bought by ins According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product titutions. This appears as high volume. Since the institutional buyer doesn’t want to buy all these shares at once and drive the price too high in one day, they will normally purchase shares over time, sometime ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in a week or a month or even several months. There are so many institutional buyers that while they are buying the volume will increase dramatically over time. This volume can be seen on charts easily. I watch f lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. r a rise in price on increased volume over at least four days in a row. I sometimes use three days, but that is much riskier. On a chart you will see the rise in stock price and the increased volume for only th here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ee to seven days. Then the stock may back off a bit or flatten out for anywhere from a few days to a year or more. This flattening is called a base if the share price remains in a tight trading range. This seem d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro to give the share price energy. If the company continues to perform well there will be a breakout on the price of the stock and it could shoot up dramatically in a short period of time. A breakout is when the ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc high point to the left of a base is reached again and on large volume rises above the previous high. This is a perfect buy point. Try not to buy the stock after it extends to far above this buy point. You will easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi usually only have a day or two to buy the stock at the perfect buy point. If it extends too high there is a chance the breakout will fail and the price of the stock could easily fall back to or below the base, nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically o be careful. A very strong stock will rise, flatten for a short time of anywhere from 3 days to 3 weeks and then breakout and shoot up again. This will happen several times so there are what looks to be tiers and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ o the chart. These are all breakouts with different buy points. The more breakouts there are the more risky the purchase if you purchase after the 3rd breakout. The institutions may start taking profits in lar ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi er groups now and the price will start to fall or flatten into another base. The length of time of the base varies so a strong company share price may move up quickly like the example I give above or the base m ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ay last for a period of months or years and be harder to spot. Look at different time periods of the charts so you have a clear overall picture of where the technical clues stand out. Of course any stock may sh dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ot up like a rocket and seem to go forever, but what goes up must come down and a stock that rises like a rocket usually falls like one too. The hard part is guessing when this fall will happen. As you can prob cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin bly tell, I don’t like to guess where money is concerned. When you have a profit of 20% in a stock make sure you never hold the stock until the profit is erased. Sell before that happens. I will sell a stock w tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen en the price backs off on higher volume for three to five days. But if the stock loses 5% to 8% immediately after I bought it, I will sell as soon as I can. If you have that 20% profit though, wait for the high t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel r volume sell signal. Sometimes the institutional traders will try to shake loose the weak, timid and scared shareholders from their shares and then drive the price higher again. This is called a shakeout. This ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust will only happen on low volume so watch for the falling share price on higher volume. This is a true sell signal. The higher your percentage gain the more room you have to maneuver as far as selling or holdin y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products the stock is concerned. If the sell signal doesn’t come you can let it ride but watch carefully in the later breakouts. After three or more breakouts the steam may be gone. You may wish to recoup your original . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de investment by selling some of your shares and letting the rest pick up any more gains or hold for a long term investment. Or you could sell enough to have a decent profit and let a smaller percentage ride. Watc elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip for the sell signals and let the rules guide you. If you sell all your shares for a 20% or more gain, don’t worry. Nobody gets broke taking a profit. Five of these trades a year and you have doubled your money tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Niche Marketing and the Demands of Outsourcing Generate More Sales in ANY Affiliate Program - Part Three
|